Morgan Stanley’s Lichen China LICN Stock Holding History

Morgan Stanley’s Portfolio LICN Stock Details LICN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-2	Closed	-$6	–	8411
2025 Q4	$6	Buy	+2	New	+$7	﹤0.01%	8149

Other funds holding LICN

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Morgan Stanley's LICN Position: Q1 2026 in Review

Morgan Stanley sold out of Lichen China (LICN) in Q1 2026, closing a stake of 2 shares — an estimated $6 sold.

Morgan Stanley first reported a position in LICN in Q4 2025 and held it in 1 quarter. The position peaked at $6 in Q4 2025. 1 fund tracked by Wall St. Rank holds LICN as of Q1 2026.

Morgan Stanley reported no remaining Lichen China position as of Q1 2026 after selling out during the quarter.
Morgan Stanley sold 2 Lichen China shares in Q1 2026, an estimated $6.
Morgan Stanley first reported a position in Lichen China in Q4 2025 and held it in 1 quarter.
Morgan Stanley's Lichen China position peaked at $6 in Q4 2025.
1 fund tracked by Wall St. Rank held Lichen China as of Q1 2026.

Based on Morgan Stanley's 13F filing for Q1 2026, filed 15 May 2026.